𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hippocampal and cardiovascular effects of muscarinic agonists

✍ Scribed by J. Loudon; F. Brown; M. Clark; G. Riley

Publisher
Springer
Year
1989
Tongue
English
Weight
65 KB
Volume
1
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Binding of agonists and antagonists to m
Binding of agonists and antagonists to muscarinic receptors
✍ Birdsall, N. J. M. ;Burgen, A. S. V. ;Hiley, C. R. ;Hulme, E. C. πŸ“‚ Article πŸ“… 1976 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 261 KB

## Abstract The binding of one irreversible and two reversible radioactive antagonists to muscarinic receptors in synaptosome preparations of rat cerebral cortex has been studied. The ligands all bind to the same receptor pool and directly and competitively yield self‐consistent binding constants c

Central muscarinic effects of physostigm
Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release
✍ David S. Janowsky; S. Craig Risch; Brian Kennedy; Michael Ziegler; Leighton Huey πŸ“‚ Article πŸ“… 1986 πŸ› Springer 🌐 English βš– 507 KB

The mechanism by which physostigmine exerts its behavioral, neuroendocrine and cardiovascular effects was explored in two separate experiments. In the first, the centrally-acting cholinesterase inhibitor physostigmine was compared with the non-centrally-acting agent neostigmine. In contrast to physo

Development of a pharmacological target
Development of a pharmacological target profile for muscarinic agonists
✍ Daniel V. Widzowski; Paul Bialobok; Kris E. Kucera; Roberta Mihut; Shawn Sitar; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

The purpose of these studies was to determine the levels of intrinsic activity in vitro at muscarinic receptor pharmacological subtypes (M 1 , M 2 , and M 3 ) that would optimize cognitive activity while minimizing acute adverse cholinergic effects in vivo. These levels of intrinsic efficacy at M 1